Göran Rådegran
41 – 50 of 158
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Plasma matrix metalloproteinase 2 is associated with severity and mortality in pulmonary arterial hypertension
- Contribution to journal › Article
-
Mark
Plasma Biomarkers for Clinical Assessment of Bone Mineral Density in Heart Transplanted Patients—A Single-Center Study at Skåne University Hospital in Lund
- Contribution to journal › Article
-
Mark
Circulating plasma microRNAs in systemic sclerosis-associated pulmonary arterial hypertension
- Contribution to journal › Article
-
Mark
The Authors' Reply to the Letter “Plasma tumour and metabolism related biomarkers differentiate PAH from HFpEF-PH may improve long-term prognosis”
- Contribution to journal › Letter
-
Mark
Higher plasma IL-6 and PTX3 are associated with worse survival in left heart failure with pulmonary hypertension
- Contribution to journal › Article
-
Mark
Association between central haemodynamics and renal function in advanced heart failure : a nationwide study from Sweden
- Contribution to journal › Article
-
Mark
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
- Contribution to journal › Article
-
Mark
Atrioventricular plane displacement and regional function to predict outcome in pulmonary arterial hypertension
- Contribution to journal › Article
- 2021
-
Mark
Underfilling decreases left ventricular function in pulmonary arterial hypertension
- Contribution to journal › Article
-
Mark
Plasma proteoglycan prolargin in diagnosis and differentiation of pulmonary arterial hypertension
- Contribution to journal › Article
